Warning: The NCBI web site requires JavaScript to function. more...
Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania.
Robberstad B, Hemed Y, Norheim OF.
Cost Eff Resour Alloc. 2007 Feb 22;5:3.
Related citations
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J, Jones J, Takeda A, Davidson P, Price A.
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL, Figgitt DP.
Pharmacoeconomics. 2004;22(6):389-411. Review.
Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY, Ko SK, Liew D.
Clin Ther. 2009 Dec;31(12):2919-30; discussion 2916-8.
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.
Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.
Cost-effectiveness of malaria control in sub-Saharan Africa.
Goodman CA, Coleman PG, Mills AJ.
Lancet. 1999 Jul 31;354(9176):378-85.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L, Mkanje R, Grosskurth H, Mosha F, Picard J, Gavyole A, Todd J, Mayaud P, Swai R, Fransen L, Mabey D, Mills A, Hayes R.
Lancet. 1997 Dec 20-27;350(9094):1805-9.
Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB.
Lancet. 1999 Sep 4;354(9181):803-9.
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.
Health Technol Assess. 2001;5(32):1-195. Review.
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.
Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.
The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.
Cleary SM, McIntyre D, Boulle AM.
Cost Eff Resour Alloc. 2006 Dec 6;4:20.
The cost-effectiveness of screening for oral cancer in primary care.
Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, Augustovski F.
Health Technol Assess. 2006 Apr;10(14):1-144, iii-iv. Review.
A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.
Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.
Robinson M, Palmer S, Sculpher M, Philips Z, Ginnelly L, Bowens A, Golder S, Alfakih K, Bakhai A, Packham C, Cooper N, Abrams K, Eastwood A, Pearman A, Flather M, Gray D, Hall A.
Health Technol Assess. 2005 Jul;9(27):iii-iv, ix-xi, 1-158. Review.
Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers M.
JAMA. 1996 Jul 10;276(2):139-45.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on